Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia (Q80962315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

B M Frost

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

E Forestier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

G Gustafsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

P Nygren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Hellebostad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

G Jonmundsson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Kanerva

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

K Schmiegelow

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

R Larsson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

G Lönnerholm

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Nordic Society for Paediatric Haematology and Oncology

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

165-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15526029%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021

Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403540

7 January 2021